6 results

• Drug Makers Abusing Law Meant To Help Meds Designed To Treat Rare Diseases: Johns Hopkins

  December 4, 2015

  Irvin Jackson

  Johns Hopkins researchers warn that the drug industry is exploiting a law meant to help unprofitable drugs meant to treat small populations with rare diseases to get big, blockbuster medications onto the market.

• Side Effects of Revlimid May Increase Cancer Risk, FDA Warns

  May 9, 2012

  Staff Writers

  An FDA investigation into the potential side effects of Revlimid, a medication for treatment of multiple myeloma, suggests that users...

• Revlimid Side Effects Linked to Risk of New Cancer: FDA

  April 11, 2011

  AboutLawsuits

  Federal health officials indicate that recent clinical trials suggest that side effects of Revlimid, which is used to treat blood...

• Treanda Stevens-Johnson Syndrome Cases Lead to New Warnings

  April 29, 2009

  AboutLawsuits

  According to Cephalon, Inc., at least two users of their cancer drug Treanda developed a severe form of the skin...

• Revlimid Stevens-Johnson Syndrome Warning Could be Added

  September 22, 2008

  AboutLawsuits

  According to drug maker Celgen Corp., the FDA will likely update the warning label for their blood-cancer drug Revlimid to...

• Revlimid Lawsuits

  September 18, 2008

  AboutLawsuits

  The blood-cancer drug Revlimid has been associated with the development of rare and potentially fatal skin reactions known as Stevens-Johnson...